Ending TB: the world's oldest pandemic.
作者信息
Kim Peter S, Swaminathan Soumya
机构信息
Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
World Health Organization, Geneva, Switzerland.
出版信息
J Int AIDS Soc. 2021 Mar;24(3):e25698. doi: 10.1002/jia2.25698.
Abstract
摘要
相似文献
1
Ending TB: the world's oldest pandemic.终结结核病：世界上最古老的大流行病。
J Int AIDS Soc. 2021 Mar;24(3):e25698. doi: 10.1002/jia2.25698.
2
The Global Fight Against Tuberculosis.全球抗击结核病
Thorac Surg Clin. 2019 Feb;29(1):19-25. doi: 10.1016/j.thorsurg.2018.09.010.
3
Trench warfare in a battle with TB.与结核病斗争中的堑壕战。
Science. 2008 Jul 18;321(5887):362-4. doi: 10.1126/science.321.5887.362.
4
Progress and challenges in childhood tuberculosis.儿童结核病的进展与挑战
Lancet Infect Dis. 2013 Apr;13(4):287-9. doi: 10.1016/S1473-3099(13)70031-8. Epub 2013 Mar 24.
5
Detection of and treatment protocol for rifampicin-monoresistant tuberculosis: what is the role of isoniazid?利福平单耐药结核病的检测与治疗方案：异烟肼的作用是什么？
Int J Tuberc Lung Dis. 2013 Jun;17(6):849-50. doi: 10.5588/ijtld.13.0066.
6
End tuberculosis by 2035: challenges ahead.到2035年终结结核病：未来的挑战
Future Microbiol. 2023 May;18:461-464. doi: 10.2217/fmb-2023-0056. Epub 2023 Jun 7.
7
Monitoring the progress achieved towards ending tuberculosis in the European Union/European Economic Area, 2018 to 2021.监测 2018 至 2021 年期间在欧盟/欧洲经济区实现终结结核病目标的进展情况。
Euro Surveill. 2023 Mar;28(12). doi: 10.2807/1560-7917.ES.2023.28.12.2300154.
8
Editorial: Updates from the World Health Organization (WHO) on Global Treatment Recommendations for Drug-Susceptible and Multidrug-Resistant Tuberculosis.社论：世界卫生组织（WHO）关于耐多药和药物敏感结核病全球治疗建议的最新情况。
Med Sci Monit. 2021 Aug 9;27:e934292. doi: 10.12659/MSM.934292.
9
[Association of tuberculosis and HIV infection in Brazil].[巴西结核病与艾滋病毒感染的关联]
Bol Oficina Sanit Panam. 1995 Jun;118(6):542-54.
10
Resistance to anti-tuberculosis medications in the Horn of Africa.非洲之角的抗结核药物耐药性。
Int J Tuberc Lung Dis. 2011 Mar;15(3):414-6.
引用本文的文献
1
Historical and Social Considerations upon Tuberculosis.关于结核病的历史与社会考量
J Prev Med Hyg. 2025 May 31;66(1):E145-E152. doi: 10.15167/2421-4248/jpmh2025.66.1.3465. eCollection 2025 Mar.
2
Rethinking approaches to overcome infectious disease.重新思考克服传染病的方法。
Nat Microbiol. 2025 Aug;10(8):1791-1792. doi: 10.1038/s41564-025-02093-6.
3
Conflation of prediction and causality in the TB literature.结核病文献中预测与因果关系的混淆。
IJTLD Open. 2025 Jul 9;2(7):388-396. doi: 10.5588/ijtldopen.25.0142. eCollection 2025 Jul.
4
Evaluating the Knowledge, Attitude, and Practice of Tuberculosis Among Health Sciences Students.评估健康科学专业学生对结核病的知识、态度和实践情况。
Healthcare (Basel). 2025 Jun 27;13(13):1534. doi: 10.3390/healthcare13131534.
5
Universal Lineage-Independent Markers of Multidrug Resistance in .通用的与谱系无关的多重耐药标志物 于……中
Microorganisms. 2024 Jun 30;12(7):1340. doi: 10.3390/microorganisms12071340.
6
Readability of Patient-Facing Information of Antibiotics Used in the WHO Short 6-Month and 9-Month All Oral Treatment for Drug-Resistant Tuberculosis.世界卫生组织推荐的用于耐多药结核病 6 个月和 9 个月全口服治疗方案中使用的抗生素患者须知的易读性。
Lung. 2024 Oct;202(5):741-751. doi: 10.1007/s00408-024-00732-z. Epub 2024 Jul 26.
7
disease associates with higher HIV-1-specific antibody responses.疾病与更高的HIV-1特异性抗体反应相关。
iScience. 2023 Apr 10;26(5):106631. doi: 10.1016/j.isci.2023.106631. eCollection 2023 May 19.
8
Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment.更新定义抗结核药物敏感性和耐药性的方法：对诊断和治疗的影响。
Eur Respir J. 2022 Apr 14;59(4). doi: 10.1183/13993003.00166-2022. Print 2022 Apr.
9
Photochemically-Mediated Inflammation and Cross-Presentation of BCG Proteins Stimulates Strong CD4 and CD8 T-Cell Responses in Mice.光化学介导的炎症和 BCG 蛋白的交叉呈递在小鼠中刺激强烈的 CD4 和 CD8 T 细胞反应。
Front Immunol. 2022 Jan 31;13:815609. doi: 10.3389/fimmu.2022.815609. eCollection 2022.
本文引用的文献
1
Xpert MTB/XDR: a 10-Color Reflex Assay Suitable for Point-of-Care Settings To Detect Isoniazid, Fluoroquinolone, and Second-Line-Injectable-Drug Resistance Directly from Mycobacterium tuberculosis-Positive Sputum.Xpert MTB/XDR：一种 10 色反射检测法，适用于即时检测，可直接从结核分枝杆菌阳性痰液中检测异烟肼、氟喹诺酮类药物和二线注射类药物耐药性。
J Clin Microbiol. 2021 Feb 18;59(3). doi: 10.1128/JCM.02314-20.
2
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.耐多药肺结核的治疗。
N Engl J Med. 2020 Mar 5;382(10):893-902. doi: 10.1056/NEJMoa1901814.
3
Prevention of tuberculosis in macaques after intravenous BCG immunization.静脉内 BCG 免疫后猕猴结核病的预防。
Nature. 2020 Jan;577(7788):95-102. doi: 10.1038/s41586-019-1817-8. Epub 2020 Jan 1.
4
GenBank.GenBank
Nucleic Acids Res. 2020 Jan 8;48(D1):D84-D86. doi: 10.1093/nar/gkz956.
5
Final Analysis of a Trial of M72/AS01 Vaccine to Prevent Tuberculosis.M72/AS01 疫苗预防结核病的试验最终分析。
N Engl J Med. 2019 Dec 19;381(25):2429-2439. doi: 10.1056/NEJMoa1909953. Epub 2019 Oct 29.
6
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.利福喷汀加异烟肼预防 HIV 相关结核病：一个月疗程。
N Engl J Med. 2019 Mar 14;380(11):1001-1011. doi: 10.1056/NEJMoa1806808.
7
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.用 H4:IC31 疫苗或 BCG 复种预防结核分枝杆菌感染。
N Engl J Med. 2018 Jul 12;379(2):138-149. doi: 10.1056/NEJMoa1714021.
8
The TB Portals: an Open-Access, Web-Based Platform for Global Drug-Resistant-Tuberculosis Data Sharing and Analysis.结核门户：一个开放获取、基于网络的全球耐多药结核病数据共享和分析平台。
J Clin Microbiol. 2017 Nov;55(11):3267-3282. doi: 10.1128/JCM.01013-17. Epub 2017 Sep 13.
9
GISAID: Global initiative on sharing all influenza data - from vision to reality.全球流感数据共享倡议组织：从愿景到现实的全球共享所有流感数据倡议
Euro Surveill. 2017 Mar 30;22(13). doi: 10.2807/1560-7917.ES.2017.22.13.30494.
10
RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration.国际研究项目报告：通过全球合作推进结核病生物标志物研究。
Clin Infect Dis. 2015 Oct 15;61Suppl 3(Suppl 3):S155-9. doi: 10.1093/cid/civ611.
Zotero 插件